Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Dr. Xiaoke (Ken) Liu, Cardiologist
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Athletes & Heart Health: Ask Mayo Clinic Health System
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
AboitizPower President and CEO Manny Rubio reviews the company's 2023 performance and provides insights in this video.
00:10:00
Keystone Law Group PLC: Full-Year Results | James Knight - Chief Executive Officer of Keystone Law.
00:10:00
Angela Durant on Nickel: Defying Supply and Demand in 2020
00:10:00
Contrarian UK Equity Specialists Unlocking Asymmetric Value in a Post-Brexit Market|Alyx Wood,CIO,Kernow Asset Management
00:10:00
Entrevista com Rogério Jorge, CEO da AES Brasil, com foco na geração de energia no Brasil.
00:10:00
The company's efforts to transition two key therapeutics targeting Alzheimer's disease and psychiatric disorders towards full commercialization|Stephan Jackman,CEO,Alzamend Neuro Inc
00:10:00
By staying ahead of technological trends and by staying connected, we can also continually optimise your technology and the service we provide you|Jonas Hasselberg,CEO,proact it group
00:00:00
Collaborate in the creation of a number of innovative community services/ Barbara Ogur, MD Associate Education Director, HMS
00:10:00
Phoenix Global Mining: Advancing the Empire Mine in Idaho
00:10:00
TechCentral Impact Series: Evolution of Cybersecurity with CYBER1 Solutions and Palo Alto Networks | Robert Brown, CEO, Cyber Security 1 ABCYB1:STO
00:10:00
Tribeca Investment Partners' Guy Keller on Nuclear Energy Opportunities Fund Performance and Uranium Market Insights
00:00:00
ONCIMMUNE HOLDINGS PLC - Strategy Update - Martin Gouldstone Chief Executive Officer, Oncimmune Holdings